SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Strategic Contract Win

10 Feb 2021 07:00

RNS Number : 5293O
PROACTIS Holdings PLC
10 February 2021
 

Proactis Holdings PLC

Strategic Contract Win

 

Proactis Holdings PLC, ("Proactis", the "Group" or the "Company"), the business spend management solution provider, is pleased to announce that it has signed a 3-year contract with an oil and gas services business in North America. This contract win represents a strategically important milestone for the Company, being the first new customer in North America to sign up under the Group's new go-to market strategy.

 

The customer, which provides coil tubing needs to oil drilling companies across six locations in North America, has selected Proactis to deliver its sourcing and supplier management requirements.

 

As announced previously, the Group adopted a new go-to market strategy for each of its US, France and Germany territories designed to replicate that of the UK and the Netherlands. This contract builds upon the contracts signed in France and Germany.

 

Tim Sykes, Chief Executive Officer at Proactis, commented:

"We are delighted to have been selected following our successes in France and in Germany. We have now demonstrated that our go to market strategy, our positioning and our solutions are relevant for our target market segment in each of the territories that we operate in. Whilst conscious that the pandemic continues to impact the pace of our progression, we grow more confident in our assessment that the market opportunity for Proactis in each of the US, France and Germany is as great as it is in the UK and the Netherlands."

 

For further information, please contact:

Proactis Holdings PLC

Tim Sykes, Chief Executive Officer

Richard Hughes, Chief Financial Officer

 

 

01937 545070 investorcontact@proactis.com

finnCap Ltd

Carl Holmes/Emily Watts/Matthew Radley - Corporate Finance

Andrew Burdis/Richard Chambers - ECM

 

0207 220 0500

 

 

Alma PR

Sam Modlin/David Ison

 

020 3405 0205

Proactis@almapr.co.uk

 

Notes to Editors:

Proactis creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,100 buying organisations around the world from the commercial, public and not-for-profit sectors.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXANEDDFEFA
Date   Source Headline
29th Apr 20217:00 amRNSInterim Results
23rd Mar 20217:00 amRNSContract Win
24th Feb 20217:01 amRNSTrading Update & Notice of Results
24th Feb 20217:00 amRNSbePayd Strategic Contract Win
10th Feb 20217:00 amRNSStrategic Contract Win
8th Jan 202111:15 amRNSHolding(s) in Company
17th Dec 20208:58 amRNSDirector/PDMR Shareholding
14th Dec 20205:19 pmRNSResult of AGM
9th Dec 20207:00 amRNSFirst bePayd contract
7th Dec 20205:00 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSNotice of AGM
2nd Dec 20207:00 amRNSDirectorate Change
30th Nov 20207:00 amRNSStrategic Contract Win
19th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20205:21 pmRNSHolding(s) in Company
3rd Nov 20205:09 pmRNSHolding(s) in Company
29th Oct 202011:40 amRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSFinal Results
19th Oct 20207:00 amRNSStrategic Contract Win
14th Oct 20207:00 amRNSNotice of Results
6th Oct 20205:02 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSDirectorate Change
2nd Sep 20205:07 pmRNSHolding(s) in Company
25th Aug 20207:00 amRNSTrading Update
13th Jul 20205:04 pmRNSHolding(s) in Company
24th Jun 20207:00 amRNSHolding(s) in Company
16th Jun 20206:16 pmRNSHolding(s) in Company
28th May 20208:27 amRNSHolding(s) in Company
27th May 20205:09 pmRNSHolding(s) in Company
22nd May 20207:00 amRNSPerformance Update
21st May 202011:50 amRNSHolding(s) in Company
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSHolding(s) in Company
6th May 20205:53 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 20203:42 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:35 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSInterim Results
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 20209:05 amRNSSecond Price Monitoring Extn
28th Apr 20209:00 amRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSReset of bank facilities
20th Apr 20207:00 amRNSCOVID-19 Update & Notice of Results
8th Apr 202010:57 amRNSHolding(s) in Company
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.